# Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack

> **NCT00132093** · PHASE4 · COMPLETED · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 100 (—)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Eplerenone

## Key facts

- **NCT ID:** NCT00132093
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132093, "Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00132093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*